A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease

NCT01132690 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer